KCNN4 and glioblastoma: Beside inducing a cyclical activation of KCa3.1 channels, FCS also promoted the stable (nonoscillatory) activation of a Cl-selective current having biophysical and pharmacological properties resembling those found for the volume-activated Cl current (ICl, swell) widely expressed in glioblastoma cells.